mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.006 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.007 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.008 |